News

Caregivers saw improvements in patients given Daybue in Rett trials

Treatment with Daybue (trofinetide) in clinical trials helped girls and young women with Rett syndrome to communicate and use their hands better, according to interviews with caregivers of participants in two studies that tested the now-approved therapy. “Caregivers from both trials described a range of improvements, including increased…

New MeCP2 mutation found in boy with Rett syndrome

Researchers identified a new mutation in the MeCP2 gene in a Chinese boy diagnosed with Rett syndrome, a condition that rarely affects males. The boy exhibited diverse symptoms, including limited movements, breathing and sleep problems, heart and lung defects, and abnormal brain wave activity. “Our discovery of…

ID’d microRNAs may serve as Rett disease progression biomarkers

A research team has identified Rett syndrome-specific molecules that regulate gene activity, called microRNAs, that are associated with the growth of patient-derived brain cells and may serve as biomarkers for monitoring Rett progression. Using 3D organoids that mimic the brain, the team identified these microRNA fingerprints within extracellular vesicles…